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ABSTRACT
Objective: To assess overall and cause-speciﬁc
mortality and the quality of somatic care among
psychiatric patients.
Design: A register-based cohort study.
Setting: All individuals aged 20e79 years in Sweden in
2005.
Participants: In total 6294339 individuals.
Primary outcome measure: The individuals were
followed for mortality in 2006 and 2007, generating
72187 deaths. Psychiatric patients were grouped
according to their diagnosis in the National Patient
Register. Mortality risk of psychiatric patients was
compared with that of non-psychiatric patients.
Estimates of RR of mortality were calculated as
incidence rate ratios (IRRs) with 95% CIs using
Poisson regression analysis. Psychiatric patients were
compared with non-psychiatric patients for three
healthcare quality indicators: the proportion of
avoidable hospitalisations, case death rate after
myocardial infarction and statin use among diabetic
patients.
Results: Compared with individuals with no episodes
of treatment for mental disorder, psychiatric patients
had a substantially increased risk of all studied causes
of death as well as death from conditions considered
amenable to intervention by the health service, that is,
avoidable mortality. The highest mortality was found
among those with another mental disorder,
predominantly substance abuse (for women, an IRR of
4.7 (95% CI 4.3 to 5.0) and for men, an IRR of 4.8
(95% CI 4.6 to 5.0)). The analysis of quality of somatic
care revealed lower levels of healthcare quality for
psychiatric patients, signalling failures in public health
and medical care.
Conclusion: This study shows a marked increase in
excess mortality, suggesting a lower quality of somatic
healthcare in psychiatric patients.
INTRODUCTION
Psychiatric patients have been reported to
have higher mortality rates and shorter life
expectancy compared with the general
population.
1e6 This applies especially to
patients with severe mental disorders, such as
schizophrenia
7e10 and bipolar disorder.
11 12
The highest risks have been found among
patients with substance abuse.
351 31 4
Psychiatric patients have a particularly
pronounced risk of suicide.
15e18 Cardiovas-
cular disease is also a major cause of excess
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ARTICLE SUMMARY
Article focus
- To investigate whether psychiatric patients have
higher overall and cause-speciﬁc mortality.
- To study whether the quality of somatic care for
psychiatric patients is different from the care
provided to patients with no concurrent mental
disorder.
Key messages
- This study shows a marked increase in excess
mortality in mentally ill men and women.
- The ﬁndings suggest a lower quality of health-
care in the treatment of somatic disorders in
psychiatric patients regarding the indicators
studied.
- Careful medical examination of psychiatric
patients together with efforts to promote
a healthier life style may be of great importance
in order to prevent, detect and treat somatic
disease.
Strengths and limitations of this study
- The strengths of the study include the popula-
tion-based design, using national registers with
high completeness.
- We were unable to study the effects of health-
related behaviours such as excessive alcohol
consumption or tobacco smoking, which is
a limitation.
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Open Access Researchdeath, partly due to a higher prevalence of smoking,
obesity and hypertension.
19e21 There are conﬂicting
data on cancer incidence and mortality in psychiatric
patients, although most studies suggest that, while
cancer mortality is higher, incidence is no different from
that of the general population.
22 23 Other potential
explanations for the excess mortality are differences in
access, provision and quality of somatic healthcare.
24 For
instance, it has been shown that people with a diagnosis
of a mental disorder have less access to primary health-
care.
25 Lower quality of diabetes care
26 and cardiovas-
cular procedures
19 27 28 have also been documented. In
Sweden, different indicators are often used as measures
reﬂecting healthcare quality.
29
The concept of avoidable mortality was introduced in
1976 as an indicator of quality of healthcare.
30 Avoidable
mortality measures deaths that could be argued to have
been avoidable either by the healthcare system or by
public health interventions and has been applied in
comparisons between regions, populations and over
time. Psychiatric patients have been shown to have
higher avoidable mortality rates than the general popu-
lation,
13 31 and questions have been raised as to whether
the medical care of physical disorders provided to
psychiatric patients is less adequate than for the popu-
lation in general.
32
The aim of this study was to investigate whether
psychiatric patients have higher overall and cause-
speciﬁc mortality and whether the quality of somatic care
for psychiatric patients is different from the care
provided to patients with no concurrent mental disorder.
Results are reported with regard to age, sex, mental
disorder and comorbid substance abuse disorders.
METHODS
Study population
The study population comprised individuals alive and
registered in Sweden in 2004 and 2005, aged 20e79
years, that is, those born between 1926 and 1985. After
excluding individuals diagnosed with mental retarda-
tion (as deﬁned by the International Classiﬁcation of
Diseases, tenth revision (ICD-10): F70eF79), the study
population comprised 6294339 individuals. The cohort
was followed from 1 January 2006 until 31 December
2007. We used the unique personal identity number
assigned to each Swedish citizen or permanent resi-
dent to link information from four population-based
registers.
33
Types of mental disorder
We identiﬁed all individuals recorded with a principal
psychiatric diagnostic code as deﬁned by ICD-10
F04eF99 (ie, dementia excluded, besides mental
retardation) in inpatient care or specialised outpatient
care in 2004 or 2005 in the National Patient Register.
The National Patient Register covers all inpatient care
in Sweden since 1987 (psychiatric inpatient care since
1973, where both alcohol and drugs services are
included) and all specialised outpatient care since
2001. If a patient had more than one discharge or
outpatient visit, the principal diagnoses from all
discharges and outpatient visits were kept to further
categorise the patients. Five mutually exclusive expo-
sure groups were created according to a hierarchy of
diagnoses: (1) schizophrenia and other non-affective
psychoses (diagnosis codes F20eF29), (2) affective
disorder (F30eF39), (3) anxiety disorder (F40eF48),
(4) other psychiatric diagnoses (F04eF99 except for
diagnoses above) and (5) persons without inpatient and
outpatient care due to mental disorder served as the
reference group.
Psychiatric in- or outpatient care due to substance
abuse disorder was also studied in a sub-analysis and was
divided into categories according to whether the
substance abuse was attributed to alcohol (F10),
narcotic-related drugs (F11eF19) or both.
As certain mental disorders, for example, bipolar
disorder and schizophrenia, are highly comorbid with
alcohol and other substance abuse,
34 schizophrenia/
other non-affective psychoses, affective or anxiety
disorder were analysed with and without a coexisting
substance abuse disorder (attributed to either alcohol or
narcotics-related drugs). In these analyses, persons
without inpatient and outpatient care due to mental
disorder served as the reference group.
Causes of death
The underlying causes of death, coded according to
ICD-10, were obtained from the Causes of Death
Register. This register contains information on all
deceased Swedish residents since 1952 and has a very
high coverage. Since 1997, all deceased have been
included, though for 0.5%, there is a lack of medical
information.
Causes of death were grouped as follows: ischaemic
heart disease (IHD) (diagnosis codes I20eI25), cancer
(C00eC97), suicide and death with undetermined
intent (X60eX84 and Y10eY34) and external causes of
death (suicide excluded) (V01eY89 (except for
X60eX84, Y10eY34)). The indicators of avoidable
mortality were divided into causes of death reﬂecting the
outcome of medical care and causes reﬂecting the effect
of the national health policy. The following diseases were
included as medical care indicators: typhoid (A01.0),
tetanus (A35), tuberculosis (A15eA19 and B90), malig-
nant neoplasm of cervix uteri (C53), Hodgkin’s disease
(C81), diabetes (E10eE14), chronic rheumatic heart
disease (I05eI09), hypertensive disease (I10eI15),
stroke (I60eI69), asthma (J45eJ46), appendicitis
(K35eK38), abdominal hernia (K40eK45), cholelithi-
asis and cholecystitis (K80eK81 and K83.0), maternal
deaths (O00eO99) and osteomyelitis (M86eM87).
Malignant neoplasms of the oesophagus (C15); malig-
nant neoplasms of the trachea, bronchus or lung (C34);
cirrhosis of the liver (K70 and K73eK74) and motor
vehicle accidents (V00eV99) were included as national
health policy indicators.
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In analyses of indicators presumably reﬂecting aspects of
healthcare quality, the age span was restricted to indi-
viduals aged 40e79 years because the studied outcomes
are rare in younger individuals. The indicator regarding
avoidable hospitalisation is based on the assumption that
unnecessary hospitalisation can be avoided if patients
with selected conditions receive proper outpatient care.
This indicator includes hospitalisations for some chronic
conditions (anaemia, asthma, diabetic complications,
heart failure, hypertension, chronic obstructive lung
disease and angina pectoris) and hospitalisations for
some acute conditions (bleeding ulcers, diarrhoea,
epileptic seizures, inﬂammatory diseases of the female
pelvic organs, pyelitis and ear, nose and throat infec-
tion). The indicator regarding 28-day case death rate
after myocardial infarction is an internationally estab-
lished indicator of how well the healthcare system
handles acute care after myocardial infarction. As a third
indicator, the proportion on treatment with lipid-
lowering drugs was measured among patients receiving
diabetes drugs. This treatment ought to be especially
important for diabetes patients, due to the many risk
factors in this population. All three indicators have been
described elsewhere.
29
Statistical analysis
Poisson regression analyses, adjusted for age, were used
to evaluate the association between mental disorder,
mortality and indicators of quality of healthcare. As
a measure of the relative occurrence of death, we used
the incidence rate ratio (IRR). We assessed person-years
at risk by adding up the years the individuals were alive
and living in Sweden during the follow-up period. SAS
Genmod procedure was used to calculate IRRs with 95%
CIs. SAS Enterprise Guide 4.2 (SAS Institute Inc.) was
used. Age-standardised percentages were calculated
when analysing differences regarding healthcare quality.
RESULTS
Cohort characteristics for the 6294339 individuals
(3141454 women and 3152885 men) are presented in
table 1. In total, 101500 women and 90946 men were
treated for mental disorder in 2004 or 2005. About 11%
of mentally ill women had a diagnosis of schizophrenia
and other non-affective psychoses, 37% affective disor-
ders, 32% anxiety disorder and 20% other psychiatric
diagnoses and for men 13%, 26%, 23% and 37%,
respectively. Almost three-quarters of the men (73%)
included in the group for other mental disorders were
treated for substance abuse.
Among all psychiatric patients, 5498 (2.9% in all, 2%
in women and 4% in men, respectively) died during the
follow-up period compared with 66689 (1.1% in all,
0.9% in women and 1.3% in men) among persons
without episodes of treatment for mental disorder.
The IRRs for different causes of death and by mental
disorder for both sexes are shown in table 2. When
compared with the general population, mortality was
considerably higher among all categories of mental
disorder and for all causes of death. The highest excess
mortality was found among individuals in the category
comprised of having another mental disorder, predom-
inantly substance abuse (for women, an IRR of 4.7 (95%
CI 4.3 to 5.0) and for men, an IRR of 4.8 (95% CI 4.6 to
5.0)).
The IRRs for different causes of death presented in
table 3 show that, regardless of mental disorder, those
with comorbid substance abuse disorders had the
highest mortality risk.
Women treated for both alcohol-related and narcotic-
related substance abuse had the highest risk for prema-
ture death, except for cancer and avoidable mortality
(table 4). Except for cancer, men treated for both
alcohol-related and narcotic-related substance abuse had
the highest risk for premature death in all studied causes
of death.
Separate analyses of different age groups 20e44,
45e64 and 65e79 showed that the younger the patient,
the more pronounced increased risk for premature
death (data not shown). This was true for all categories
of mental disorder and for all studied causes of death,
except for suicide.
The majority of patients (78% of women and 77% of
men) with affective and anxiety disorders had been
treated in outpatient care only. For the other disorders,
around half of the patients had been treated in outpa-
tient care only. Mortality rates were higher among those
hospitalised than those treated in outpatient care. This
was true for all categories of mental disorders and for all
causes of death (data not shown).
The different healthcare quality indicators are
presented in table 5. The percentage of avoidable
admissions was higher among people treated for mental
disorder, for women spanning from 2.4% to 4.1%
(compared with 1.1% for those without episodes of
treatment for mental disorder) and for men spanning
from 3.4% to 5.4% (compared with 1.6%). Psychiatric
patients had a higher 28-day case death rate for
myocardial infarction, especially those treated for
schizophrenia and other non-affective psychoses
(women 53.5% (42.0e65.0) and men 51.4%
(40.4e62.3)) compared with 26.5% of women
(25.7e27.3) and 28.1% (27.5e28.6) of men not treated
for mental disorder. The indicator on lipid-lowering
drug therapy shows that psychiatric patients with dia-
betes were given lipid-lowering drugs to a lesser extent
than diabetic patients without a concurrent mental
disorder; this was particularly evident among both
women and men with schizophrenia and other non-
affective psychoses.
DISCUSSION
Our study of more than 6 million women and men shows
that psychiatric patients had a substantially increased risk
of death compared with individuals with no episodes of
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death. Overall, people with schizophrenia and other
non-affective psychoses and people treated for substance
abuse disorder had the highest risk for premature death.
Psychiatric patients also had higher rates of potentially
avoidable hospitalisations, higher case death rate after
myocardial infarction and lower use of lipid-lowering
therapy in diabetes.
The strengths of the study include the population-
based design, using national registers with high
completeness. The validity in the Causes of Death
Register is very high, where information of cause of
death is lacking in only 0.5% of the deceased.
35 The
National Patient Register has close to complete coverage
of all inpatient care. However in 2005, around 40% of
psychiatric outpatient visits were not included, hence
some patients who were treated in outpatient care are
classiﬁed as unexposed, as there is no record of their
outpatient visit. Also, as the National Patient Register
does not cover primary care, we were not able to study all
levels of psychiatric care. Hence, patients treated for
mental health problems solely in primary care are clas-
siﬁed as unexposed. Assuming a similar effect for
patients in primary care as for psychiatric patients in our
study selected by a more strict deﬁnition of mental
health problems, that is, patients who have seen
a psychiatrist, this misclassiﬁcation will dilute our results
towards the null. We were unable to study the effects of
health-related behaviours such as excessive alcohol
consumption or tobacco smoking, which is a limitation.
We found that psychiatric patients were at higher risk
of premature death from IHD, particularly among those
treated for schizophrenia and other non-affective
psychoses. This has previously been shown in other
settings,
10 11 19 20 and recently a study showed that the
excess cardiovascular mortality among schizophrenia
patients has increased over the past 25 years.
7 We also
found an elevated risk for cancer mortality, although to
a lesser extent, in particular in patients treated for
schizophrenia and other non-affective psychoses and
substance abuse disorders. Studies evaluating cancer
incidence and mortality at the same time have shown
that, while individuals with mental disorder did not show
any increased incidence rate for many types of cancer,
they did have higher cancer mortality, which might be
explained by delays in detection,
23 36 disparities in
screening for cancer
22 and treatment compliance.
37
Psychiatric patients had an elevated risk of premature
death from conditions considered amenable to inter-
vention by the health service, that is, avoidable mortality,
compared with those not treated in psychiatric care. In
particular, those treated for schizophrenia with
comorbid substance abuse disorder had a higher risk,
which has been shown by others.
13 31
In line with previous studies, we found psychiatric
patients to have signiﬁcantly higher suicide risk, in
particular those treated for schizophrenia and other
non-affective psychosis, and affective disorder and
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Quality of medical care and excess mortality in psychiatric patientsespecially those treated with a comorbid substance abuse
disorder.
17
Psychiatric patients also had substantially increased
risk of deaths from external causes when suicide was
excluded. Studies have shown that people with mental
disorder are at greater risk of accidental and violent
death, particularly when alcohol and narcotic-related
drug comorbidities are involved.
38 As mentioned earlier,
our results showed that mentally ill individuals with
a coexisting substance abuse disorder have signiﬁcantly
higher risk for premature death. When we excluded
those with a coexisting substance abuse disorder, the
increased mortality risk remained for all diagnosis
groups except for schizophrenia and other non-affective
psychosis, but with lower estimates (data not shown).
Consistent with previous research, substance abuse
disorders strongly contributed to premature death among
both female and male psychiatric patients, especially for
those with both alcohol and narcotic-related drug abuse.
When studying a set of indicators aimed to reﬂect the
outcome of healthcare quality, we found that patients
with a mental disorder had higher rates of potentially
avoidable hospitalisations. Under some circumstances,
hospitalisation is necessary and well motivated, but for
most studied diseases, it is a failure. A recent study on
avoidable hospitalisation demonstrated that the quality
of physical healthcare received by patients with schizo-
phrenia was poorer than that of the general population,
signalling failures in public health and medical care.
34
The indicator of 28-day case death rate after myocar-
dial infarction showed worse outcome for those with
a mental disorder. In a Danish study,
19 less somatic
hospitalisation than needed and less use of invasive heart
disease procedures among persons with severe mental
disorder than among the general population were
suggested as additional reasons for their excess mortality
in IHD.
Another ﬁnding was the low percentage of lipid-
lowering drugs given to diabetic patients with a concur-
rent mental disorder. As drug therapy against lipid
disorders is particularly important in diabetic patients,
39
this is a clear indication of inequality in healthcare.
Disparities in access to and utilisation of healthcare, as
well as the quality of healthcare provision, may
contribute to inequalities in health.
40 One reason for
these disparities could be that a person with mental
disorder may not be able to effectively communicate and
express concerns because of cognitive disturbance. Also,
psychiatrists and other mental health providers may
prioritise psychiatric issues and neglect physical prob-
lems.
41 There is also some evidence of inequalities in
case recognition and quality of medical care for psychi-
atric patients, where general practitioners might mini-
mise the clinical signiﬁcance of physical complaints
when assessing and treating patients with a mental
disorder, a process known as diagnostic over-
shadowing.
42 As there is excess mortality across a wide
range of mental disorders, somatic care should be
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Quality of medical care and excess mortality in psychiatric patientsimproved for all psychiatric patients, regardless of the
severity of the mental disorder.
In addition to inequalities in utilisation and quality of
healthcare, there are many factors that contribute to
poor physical health in people with a mental disorder,
including health-related behaviours and medication
side-effects. The increased morbidity and mortality seen
in this population are largely due to a higher prevalence
of modiﬁable risk factors, many of which are related to
health-related behaviours. The use of alcohol and illicit
drugs is more common among psychiatric patients. It is
also known that psychiatric patients smoke to a larger
extent,
3 43 which could be an explanation for the
increased mortality in IHD and cancer. Regardless of the
kind of mental disorder, we found psychiatric patients to
have an increased risk of dying in smoking-related
cancer (data not shown). An unhealthy diet may also
elevate the risk of various somatic diseases and thus
increase the risk of death. The effects of these health-
related behaviours have all been proposed as possible
causative factors for excess mortality.
44 Also, medications
used to treat severe mental disorder may increase the
risk of diabetes and cardiovascular disease, as most mood
stabilisers are associated with weight gain.
12 45 However,
these factors make careful monitoring of the physical
health status of patients with mental disorders even
more important.
CONCLUSIONS
This study shows a marked increase in excess mortality in
mentally ill women and men. This was especially evident
in individuals with a comorbid substance abuse disorder.
The ﬁndings also suggest a lower quality of healthcare in
the treatment of somatic disorders in psychiatric
patients. Careful medical examination of psychiatric
patients together with efforts to promote a healthier life
style may be of great importance in order to prevent,
detect and treat somatic disease.
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